Alternative Data for Allstate
About Allstate
Allstate Corp, through its subsidiaries, is primarily engaged in the property-liability insurance business and the life insurance, retirement and investment products business. It offers its products in the United States and Canada.
| Price | $206.17 |
| Target Price | Sign up |
| Volume | 1,407,730 |
| Market Cap | $53.5B |
| Year Range | $188.14 - $214.18 |
| Dividend Yield | 1.95% |
| PE Ratio | 5.42 |
| Analyst Rating | 82% buy |
| Industry | Insurance |
In the news
 |
Insurers Under Allstate Group File Louisiana Rate Decreases for Personal AutoMarch 13 - Insurance Journal |
ALLSTATE 'illegally tracked drivers without their knowledge'...March 5 - The-sun.com |
|
 |
Allstate ordered to face privacy lawsuit alleging drivers were tracked through cellphonesMarch 4 - New York Post |
 |
Allstate must face privacy lawsuit over cellphone tracking of driversMarch 4 - CNA |
 |
Is It Worth Investing in Allstate (ALL) Based on Wall Street's Bullish Views?February 23 - Yahoo |
|
Is the Options Market Predicting a Spike in Allstate Stock?February 23 - Yahoo |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q4 '25 | 16.6B | 7.8B | 8.79B | 3.83B | 5.01B | 14.310 |
| Q3 '25 | 17.1B | 10.8B | 6.24B | 3.75B | 5.04B | 11.170 |
| Q2 '25 | 16.5B | 12.5B | 4.03B | 2.11B | 2.93B | 5.940 |
| Q1 '25 | 16.3B | 13.2B | 3.03B | 595M | 951M | 3.530 |
| Q4 '24 | 16.3B | 11.4B | 4.92B | 1.93B | 2.7B | 7.670 |
Insider Transactions View All
| WILSON THOMAS J filed to sell 92,532 shares at $213.5. March 4 '26 |
| WILSON THOMAS J filed to sell 93,443 shares at $212.7. March 4 '26 |
| WILSON THOMAS J filed to sell 100,055 shares at $211.9. March 4 '26 |
| Merten Jesse E filed to sell 32,301 shares at $210.4. February 26 '26 |
| Merten Jesse E filed to sell 33,601 shares at $209.4. February 26 '26 |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
ProgressivePGR |
$205.17 0% | 54 |
 |
MetLifeMET |
$67.97 1.2% | 47 |
 |
AflacAFL |
$108.71 0.8% | 31 |
 |
LemonadeLMND |
$55.15 4.3% | 65 |
 |
Oscar HealthOSCR |
$13.23 1.8% | 35 |
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Julie Johnson |
May 15, 25 | Sell | $1K - $15K |
| Ro Khanna |
Dec 6, 24 | Sell | $1K - $15K |
| Ro Khanna |
Dec 6, 24 | Sell | $1K - $15K |
Read more about Allstate (ALL) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, app downloads, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, threads followers, tiktok followers, x followers, x mentions, youtube subscribers, news mentions, customer reviews, lobbying cost, business outlook & linkedin employees.
FAQ - Allstate
The Market Cap of Allstate is $53.5B.
As of today, Allstate's PE (Price to Earnings) ratio is 5.42.
Currently, the price of one share of Allstate stock is $206.17.
The ALL stock price chart above provides a comprehensive visual representation of Allstate's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Allstate shares. Our platform offers an up-to-date ALL stock price chart, along with technical data analysis and alternative data insights.
Yes, Allstate (ALL) offers dividends to its shareholders, with a dividend yield of 1.95%. This dividend yield represents Allstate's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering Allstate in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.
Some of the similar stocks of Allstate are Progressive, MetLife, Aflac, Lemonade, and Oscar Health.
